samedan logo
 
 
 
spacer
home > pmps > autumn 2008 > lean machine
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Lean Machine

Pharmaceutical manufacturing costs the industry approximately $90 billion each year and represents twice the expenditure of R&D (1). A 2001 study conducted by the MIT Pharmaceutical Manufacturing Initiative (PHARMI) indicated that significant time was spent conducting quality control (QC) testing and documenting QC results during the manufacturing process (2). Eroding profit margins from stiff competition, increasing product defects, and the FDA’s focus on a ‘quality by design model’ has led the industry to reevaluate manufacturing efficiency (1,3). The industry has recently begun adopting both lean manufacturing and Six Sigma to achieve the efficiency and quality gains achieved by other industries (4-6). IT solutions will play a significant role in managing QC standard operating procedure (SOP) documentation during the focus on lean and Six Sigma to eliminate waste, improve...

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Chris Stumpf joined Waters in 2001 after earning his PhD in Analytical Chemistry and Mass Spectrometry from Purdue University in 2000, and held a post doctoral position at the University of Cincinnati Medical School conducting proteomics research. During his doctorate and post-doctorate education, he became keenly interested in informatics solutions to manage and mine analytical data.

Phil Kilby joined Waters in 1998. He received a degree in Chemistry from Greenwich University while working in drug metabolism at Rhone Poulenc in London. He is now responsible for worldwide business and partnership development of Waters’ suite of informatics solutions. Email: phil_kilby@waters.com

spacer
Chris Stumpf
spacer
spacer
spacer
Phil Kilby
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Biopharmaceuticals company attends sector conferences in the online format

A leading Contract Development and Manufacturing Organization (CDMO), 3P Biopharmaceuticals, specialized in process development and cGMP manufacturing of biologics, is attending the most relevant events of the sector, although in digital format, as a consequence of the cancellation of global events due to the pandemic. COVID19 has affected everyone and all sectors.
More info >>

White Papers

Points to Consider When Developing a TMF (Trial Master File) Strategy

Phlexglobal Ltd

Many organizations are currently outsourcing clinical trial activities to one or more contract research organizations (CROs). This strategy enables companies to leverage specialized expertise and take advantage of flexible resourcing throughout the conduct of a clinical trial. Outsourcing minimizes the costs of recruiting experts, building a team and maintaining an infrastructure. However, it can also add complexity as the organization looks to meets its compliance obligations regarding clinical trial documentation. The documentation referred to in Article 15(5) of Directive 2001/20/EC as the trial master file shall consist of essential documents, which enable both the conduct of a clinical trial and the quality of the data produced to be evaluated.1 This essential study specific documentation is also known as the TMF. As organizations try to minimize their reliance on paper files, the electronic TMF (eTMF) has emerged. A current industry initiative to standardize the organization of this content is known as the TMF Reference Model. This model is helping standardization efforts across paper and electronic systems. As companies implement outsourcing strategies, CROs and sponsor organizations look for a common foundation on which to build their TMF capabilities. The following paper outlines some of the challenges organizations face when outsourcing clinical trial activities to multiple contract research organizations and a strategy to facilitate partnering and management of trial information between sponsors and CROs.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement